Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
99.832,35
-0,83%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Nautilus Biotechnology Inc (NAUT) Nautilus Biotechnology Inc (NAUT) Notizie

Nautilus Biotechnology Inc

NAUT
1,71
-0,06 (-3,39%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/1/202523:15EDGAR2Form 8-K - Current report
31/10/202413:00GLOBENautilus Biotechnology Co-founder and Chief Scientist Parag..
30/10/202413:00GLOBENautilus Biotechnology to Participate in the Inaugural..
29/10/202421:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202413:00GLOBENautilus Biotechnology Reports Third Quarter 2024 Financial..
08/10/202414:00GLOBENautilus Biotechnology to Announce Third Quarter 2024..
17/9/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202422:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/9/202414:00GLOBENautilus Biotechnology Appoints Mass Spectrometry Leader Ken..
14/8/202414:00GLOBENautilus Biotechnology to Participate in the Morgan Stanley..
30/7/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/7/202414:00GLOBENautilus Biotechnology Reports Second Quarter 2024 Financial..
09/7/202414:00GLOBENautilus Biotechnology to Announce Second Quarter 2024..
17/6/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202422:25EDGAR2Form 8-K - Current report
23/5/202414:00GLOBENautilus Biotechnology to Participate in the Goldman Sachs..
30/4/202414:00GLOBENautilus Biotechnology Reports First Quarter 2024 Financial..
11/4/202414:00GLOBENautilus Biotechnology to Announce First Quarter 2024..
07/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/3/202422:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/3/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202414:00GLOBENautilus Biotechnology Reports Fourth Quarter and Fiscal..
28/2/202413:26EDGAR2Form 8-K - Current report
28/2/202413:25EDGAR2Form S-3 - Registration statement under Securities Act of..
28/2/202413:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202413:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202413:03EDGAR2Form 8-K - Current report
22/2/202414:00GLOBENautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ..
07/2/202414:00GLOBENautilus Biotechnology to Announce Fourth Quarter and Full..
Apertura: 1,76 Min: 1,6943 Max: 1,80
Chiusura: 1,77

La tua Cronologia

NASDAQ
NAUT
Nautilus Biotechnology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci